Cata-Kor Enters Research Agreement with KGK Science to Launch Human Clinical Trial on NAD+ Advanced
Cata-Kor partners with KGK Science for human clinical trial on NAD+ Advanced supplement to validate efficacy and safety. MIAMI, FL, UNITED STATES, October 23, 2025 /EINPresswire.com/ -- Cata-Kor, a U.S.-based nutraceutical company, today announced that …